Combined endocrine approaches vs endocrine therapy alone as first line treatment in elderly patients with hormone receptor-positive, HER2 negative, advanced breast cancer: to prescribe for the patient or the physician? A meta-analysis of phase II and III randomized clinical trials. BMC Cancer

Combined endocrine approaches vs endocrine therapy alone as first line treatment in elderly patients with hormone receptor-positive, HER2 negative, advanced breast cancer: to prescribe for the patient or the physician? A meta-analysis of phase II and III randomized clinical trials. BMC Cancer / Omarini, C; Piacentini, F; Sperduti, I; Barbolini, M; Isca, C; Toss, A; Cortesi, L; Barbieri, E; Dominici, M; Moscetti, L. - In: BMC CANCER. - ISSN 1471-2407. - (2020), pp. 418-425.